Lymphoma of cytotoxic/suppressor T cell phenotype (T8) following angioimmunoblastic lymphadenopathy

Arye Rubinstein, Leonard G. Dauber

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


A patient with angioimmunoblastic lymphadenopathy was treated with chemotherapy to complete remission for 13 years. A single relapse, self-limited, occurred followed 2 years later by the appearance of a disseminated non-Hodgkin's lymphoma with prominent cutaneous lesions and hypogammaglobulinemia. Cells from the peripheral blood and an affected lymph node were characterized by immunologic studies as deriving from the T8 subset of lymphocytes, suggesting a functional relationship between these suppressor cells and the patient's clinical manifestations.

Original languageEnglish (US)
Pages (from-to)195-199
Number of pages5
JournalOncology (Switzerland)
Issue number3
StatePublished - 1983


  • Angioimmunoblastic lymphadenopathy
  • Lymphoma
  • T suppressor cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Lymphoma of cytotoxic/suppressor T cell phenotype (T8) following angioimmunoblastic lymphadenopathy'. Together they form a unique fingerprint.

Cite this